Karen Dawes, president of Knowledgeable Decisions LLC, was
recently named co-chairperson of the board of directors at Repligen.
She has served as a director of Repligen since September of 2005,
and will co-chair the company with Alexander Rich.
Repligen is a biopharmaceutical company focused on marketing new
protein therapy-based drugs in the fields of neurology and
gastroenterology. The Waltham-based company also develops and
manufactures biologics products.
